Sabrina Divekar

Papers

1

Total Citations

2

H-Index

1

About

Sabrina Divekar is a biomedical researcher whose work sits at the intersection of radiation oncology and emerging antimitotic therapies. Her primary research focuses on the integration of Tumor Treating Fields (TTFields) with advanced radiation delivery techniques, particularly robotic hypofractionated radiation therapy. In her most-cited paper, "Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy" (2021), Divekar addressed a critical clinical challenge: how to deliver concurrent TTFields and radiation without compromising targeting precision. This work helped establish the feasibility of combining these two modalities in a single treatment session, a concept with significant implications for glioblastoma and other aggressive tumors. While her citation count is still growing—a reflection of her early-career stage—Divekar’s contributions are notable for their translational focus, bridging physics, engineering, and oncology. Her research has been instrumental in shaping protocols for simultaneous TTFields and radiotherapy, a frontier that promises to improve outcomes for patients with treatment-resistant cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
2 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago